REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmigene, Inc. (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Pharmigene, Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Pharmigene, Inc. focuses on the R&D, production and sales of medical testing products or diagnostic tools. The company was founded in 2005 and is headquartered in Taiwan.

Headquarters
4F., No. 17, Ln. 171, Sec. 2, Jiuzong Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Pharmigene, Inc. report to view the information.

Website: http://www.pharmigene.com.tw

Basic Information
Total Employees:
Purchase the Pharmigene, Inc. report to view the information.
Outstanding Shares:
Purchase the Pharmigene, Inc. report to view the information.
Financial Auditors:
Purchase the Pharmigene, Inc. report to view the information.
Incorporation Date:
September 28, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
16.5%
Purchase this report to view the information.
11.4%
Purchase this report to view the information.
2.07%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
Subsidiaries
Pharmigene Biomedical Pte.,Lid (Singapore)
100%
Pharmigene Inc (United States)
100%
Reach Rich Global Co.,Ltd. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Pharmigene, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-10.5%▼
Total operating revenue
-13.85%▼
Operating profit (EBIT)
-44.47%▼
EBITDA
-105.45%▼
Net Profit (Loss) for the Period
-69.82%▼
Total assets
11.68%▲
Total equity
19.31%▲
Operating Profit Margin (ROS)
-32.26%▼
Net Profit Margin
-48.01%▼
Return on Equity (ROE)
-3.71%▼
Debt to Equity Ratio
-15.38%▼
Quick Ratio
3.42%▲
Cash Ratio
0.86%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo